Imugene Ltd (IMU) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.620x

Based on the latest financial reports, Imugene Ltd (IMU) has a cash flow conversion efficiency ratio of -0.620x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-25.97 Million ≈ $-18.38 Million USD) by net assets (AU$41.87 Million ≈ $29.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Imugene Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)

This chart illustrates how Imugene Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Imugene Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Imugene Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imugene Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Proteomics International Laboratories Ltd
AU:PIQ
-0.416x
Richmond Vanadium Technology Ltd
AU:RVT
-0.025x
Agroton Public Ltd.
WAR:AGT
-0.142x
Perdana Gapura Prima Tbk
JK:GPRA
0.078x
Old Market Capital Corporation
NASDAQ:OMCC
-0.002x
Evaxion Biotech AS
NASDAQ:EVAX
-0.121x
Fathom Holdings Inc
NASDAQ:FTHM
-0.318x
Hitron Systems
KO:019490
-0.277x

Annual Cash Flow Conversion Efficiency for Imugene Ltd (1993–2025)

The table below shows the annual cash flow conversion efficiency of Imugene Ltd from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see Imugene Ltd (IMU) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$45.03 Million
≈ $31.86 Million
AU$-75.57 Million
≈ $-53.47 Million
-1.678x -95.07%
2024-06-30 AU$118.25 Million
≈ $83.67 Million
AU$-101.73 Million
≈ $-71.98 Million
-0.860x -447.78%
2023-06-30 AU$189.63 Million
≈ $134.17 Million
AU$-29.78 Million
≈ $-21.07 Million
-0.157x +28.98%
2022-06-30 AU$138.70 Million
≈ $98.14 Million
AU$-30.67 Million
≈ $-21.70 Million
-0.221x -9.50%
2021-06-30 AU$65.02 Million
≈ $46.00 Million
AU$-13.13 Million
≈ $-9.29 Million
-0.202x -19.19%
2020-06-30 AU$59.81 Million
≈ $42.32 Million
AU$-10.13 Million
≈ $-7.17 Million
-0.169x +41.54%
2019-06-30 AU$27.29 Million
≈ $19.31 Million
AU$-7.91 Million
≈ $-5.60 Million
-0.290x +0.52%
2018-06-30 AU$15.48 Million
≈ $10.95 Million
AU$-4.51 Million
≈ $-3.19 Million
-0.291x -24.18%
2017-06-30 AU$11.39 Million
≈ $8.06 Million
AU$-2.67 Million
≈ $-1.89 Million
-0.235x +39.56%
2016-06-30 AU$7.86 Million
≈ $5.56 Million
AU$-3.05 Million
≈ $-2.16 Million
-0.388x -46.86%
2015-06-30 AU$7.73 Million
≈ $5.47 Million
AU$-2.04 Million
≈ $-1.45 Million
-0.264x -55.52%
2014-06-30 AU$6.73 Million
≈ $4.76 Million
AU$-1.14 Million
≈ $-809.52K
-0.170x +76.58%
2013-06-30 AU$1.89 Million
≈ $1.33 Million
AU$-1.37 Million
≈ $-968.40K
-0.726x +19.38%
2012-06-30 AU$1.07 Million
≈ $759.51K
AU$-965.92K
≈ $-683.45K
-0.900x -447.17%
2011-06-30 AU$4.21 Million
≈ $2.98 Million
AU$1.09 Million
≈ $771.53K
0.259x +156.39%
2010-06-30 AU$3.79 Million
≈ $2.68 Million
AU$-1.74 Million
≈ $-1.23 Million
-0.460x -377.67%
2009-06-30 AU$5.33 Million
≈ $3.77 Million
AU$881.77K
≈ $623.91K
0.166x +160.74%
2008-06-30 AU$4.67 Million
≈ $3.30 Million
AU$-1.27 Million
≈ $-900.66K
-0.273x +24.77%
2007-06-30 AU$4.70 Million
≈ $3.33 Million
AU$-1.70 Million
≈ $-1.20 Million
-0.362x -27.73%
2006-06-30 AU$6.46 Million
≈ $4.57 Million
AU$-1.83 Million
≈ $-1.30 Million
-0.284x -50.67%
2005-06-30 AU$8.65 Million
≈ $6.12 Million
AU$-1.63 Million
≈ $-1.15 Million
-0.188x +32.68%
2004-06-30 AU$5.43 Million
≈ $3.84 Million
AU$-1.52 Million
≈ $-1.07 Million
-0.280x +71.84%
2002-06-30 AU$792.83K
≈ $560.98K
AU$-787.36K
≈ $-557.11K
-0.993x -108.81%
2001-06-30 AU$-226.54K
≈ $-160.29K
AU$-2.55 Million
≈ $-1.81 Million
11.266x +892.20%
2000-06-30 AU$2.78 Million
≈ $1.97 Million
AU$-3.95 Million
≈ $-2.80 Million
-1.422x -147.09%
1999-06-30 AU$6.00 Million
≈ $4.24 Million
AU$-3.45 Million
≈ $-2.44 Million
-0.576x -99.40%
1997-06-30 AU$7.45 Million
≈ $5.27 Million
AU$-2.15 Million
≈ $-1.52 Million
-0.289x -16.06%
1996-06-30 AU$8.12 Million
≈ $5.75 Million
AU$-2.02 Million
≈ $-1.43 Million
-0.249x -58.27%
1995-06-30 AU$10.62 Million
≈ $7.52 Million
AU$-1.67 Million
≈ $-1.18 Million
-0.157x -20.81%
1994-06-30 AU$11.19 Million
≈ $7.91 Million
AU$-1.46 Million
≈ $-1.03 Million
-0.130x -235.76%
1993-06-30 AU$5.11 Million
≈ $3.62 Million
AU$-198.00K
≈ $-140.10K
-0.039x --

About Imugene Ltd

AU:IMU Australia Biotechnology
Market Cap
$28.04 Million
AU$39.63 Million AUD
Market Cap Rank
#23928 Global
#965 in Australia
Share Price
AU$0.11
Change (1 day)
+4.76%
52-Week Range
AU$0.01 - AU$0.48
All Time High
AU$0.61
About

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA,… Read more